Tratamiento de la neumonía adquirida en la comunidad en hospitalización a domicilio: resultado clínico en casos con diferente nivel de gravedad / Efficacy of hospital at home (HaH) in the treatment of community-acquired pneumonia (CAP) with different degrees of severity

Fundamento y objetivo: Diferentes sociedades científicas proponen el uso de escalas de severidad más otros criterios adicionales para determinar el lugar de tratamiento de la neumonía adquirida en la comunidad. El objetivo de este estudio es correlacionar el riesgo según 3 reglas de predicción clínica (PSI, CURB-65 y PSCURXO-80) y criterios adicionales con la efectividad de la hospitalización a domicilio (HaD).Pacientes y método: Revisión de los casos de neumonía adquirida en la comunidad remitidos por el servicio de urgencias a HaD entre enero de 2000 y mayo de 2008. Se clasifican según 3 escalas de riesgo y presencia de criterios adicionales y se analiza su asociación con la inefectividad de HaD durante el tratamiento.Resultados: Se admitieron 146 mujeres y 181 hombres (edad media=60,3 años). La media de estancia en HaD fue de 8,6 días. Dos pacientes murieron, 25 (7,7%) fueron reenviados a hospitalización convencional, 219 fueron dados de alta sin incidencias y 81 tras superar complicaciones. La HaD fue efectiva en el 92,3% de los pacientes. El porcentaje fue del 85% para PSI=IV o V sin o con CA, del 80% para CURB-65=2 y del 77,5% para valores entre 10–19 de PSCURXO-80. La eficacia de HaD se relaciona inversamente con la severidad.Conclusiones: La eficacia de HaD en el tratamiento de neumonía adquirida en la comunidad es menor en los pacientes con mayor gravedad definida por medio de diferentes escalas de predicción clínica, pero es eficaz en un elevado porcentaje de casos en los que está indicado el ingreso hospitalario (AU)

Background and objective: Different scientific societies propose the use of scales of severity and additional criteria (AC) in order to determine the setting for the treatment of Community-Acquired Pneumonia (CAP).The objective of this study is to correlate the risk regarding three clinical prediction rules (PSI, CURB-65 and PSCRUXO-80) and AC with the effectiveness of hospital at home (HaH). Patients and method: Evaluation of cases of CAP referred from the Emergency Unit to HaH between January 2000 and May 2008. They were classified regarding three risk scales and presence of AC and its association with the effectiveness of HaH during the treatment was analysed. Results: 146 women and 181 men were admitted, (mean age, 60.3 years). The average stay in HaH was 8.6 days. Two patients died, 25 (7.7%) were admitted to hospital, 219 progressed favourably throughout and 81 after overcoming complications. Hospital at Home was effective in 92.3% of total patients. The rate was 85% for those in PSI=IV or V with or without additional criteria; 80% for CURB-65=2 and 77.5% for a PSCURXO-80 score of 10–19. The effectiveness of HaH is inversely related to severity (AU)ConclusionsHospital a Home (HaD) is an effective and safe care option for many cases of CAP in which hospital admission is normally recommended on the basis of prediction rule scores or additional admission criteria

[Efficacy of hospital at home (HaH) in the treatment of community-acquired pneumonia (CAP) with different degrees of severity]. / Tratamiento de la neumonía adquirida en la comunidad en hospitalización a domicilio: resultado clínico en casos con diferente nivel de gravedad.

BACKGROUND AND OBJECTIVE: Different scientific societies propose the use of scales of severity and additional criteria (AC) in order to determine the setting for the treatment of Community-Acquired Pneumonia (CAP).The objective of this study is to correlate the risk regarding three clinical prediction rules (PSI, CURB-65 and PSCRUXO-80) and AC with the effectiveness of hospital at home (HaH). PATIENTS AND METHOD: Evaluation of cases of CAP referred from the Emergency Unit to HaH between January 2000 and May 2008. They were classified regarding three risk scales and presence of AC and its association with the effectiveness of HaH during the treatment was analysed. RESULTS: 146 women and 181 men were admitted, (mean age, 60.3 years). The average stay in HaH was 8.6 days. Two patients died, 25 (7.7%) were admitted to hospital, 219 progressed favourably throughout and 81 after overcoming complications. Hospital at Home was effective in 92.3% of total patients. The rate was 85% for those in PSI=IV or V with or without additional criteria; 80% for CURB-65=2 and 77.5% for a PSCURXO-80 score of 10-19. The effectiveness of HaH is inversely related to severity. CONCLUSIONS: Hospital a Home (HaD) is an effective and safe care option for many cases of CAP in which hospital admission is normally recommended on the basis of prediction rule scores or additional admission criteria.

Tratamiento del absceso hepático: nueva evidencia de la utilidad de la hospitalización a domicilio / Treatment of liver abscesses: new evidence of the usefulness of hospital at home

No disponible

No disponible

[Home intravenous antibiotic treatment: a study in 515 patients]. / Antibioterapia intravenosa en domicilio. Estudio de 515 casos.

OBJECTIVE: To assess the effectiveness of therapy, type of infection, hospital department of origin and outcome of 515 cases of infection requiring home intravenous antibiotic therapy treated by the home care service. METHODS: The clinical records of patients undergoing intravenous antibiotic therapy through the home care service over a 6-year period were retrospectively reviewed. RESULTS: A total of 439 patients (244M/195F; mean age, 55.9 years, range 7-96) requiring 515 courses of home intravenous antibiotic therapy were reviewed. Mean duration of antibiotic therapy was 7.9 days (1-58). Urinary (42.3%) and respiratory infections (25.8%) were the most frequent indications for home treatment. Most patients were referred from the emergency room (50.5%) followed by the Internal Medicine Department (11.5%) and Oncology Department (11.1%). Ceftriaxone was the most widely prescribed antibiotic (41.8%) followed by aminoglycosides (35.3%) and glycopeptides (11.7%). In 49 cases electronic infusion pumps were used, with ceftazidime being the predominant antibiotic (32.7%) in these cases. Hospitalization was required in 7% of patients due to infectious disease-related complications. Clinical outcome was positive in 79% of the patients, with improvement in 90% of patients from the emergency room CONCLUSIONS: The advantages of home care services to provide home intravenous antibiotic therapy are evident. More than half of the patients were referred from the emergency room and 90% of these progressed well. The presence of medical and nursing staff qualified to handle infectious diseases is necessary, as well as continuing home care.

Antibioterapia intravenosa en domicilio. Estudio de 515 casos / Home intravenous antibiotic treatment: A study in 515 patients

Objetivo. Valorar la efectividad, tipo de infección, servicio de procedencia y pronóstico de 515 casos tratados con antibioterapia intravenosa en domicilio en una Unidad de Hospitalización a Domicilio (UHD). Métodos. Estudio retrospectivo de un período de 6 años de las historias clínicas de los pacientes ingresados en la UHAD que recibieron antibióticos intravenosos. Resultados. Se trataron 439 pacientes (244 hombres y 195 mujeres) que generaron 515 casos. La edad media fue de 55,9 (límites: 7-96 años). La duración media del tratamiento antibiótico intravenoso en domicilio fue de 7,9 días (límites: 1-58 días). La localización infecciosa más frecuente fue la urinaria (42,3%) seguida de la respiratoria (25,8%). El servicio de procedencia que más pacientes remitió fue urgencias (50,5%) seguido de medicina interna (11,5%) y oncología (11,1%). La ceftriaxona fue el antibiótico más utilizado (41,8%), seguido de los aminoglucósidos (35,3%) y glucopéptidos (11,7%). En 49 ocasiones se utilizaron bombas programables de perfusión, siendo el antibiótico más utilizado la ceftazidima (32,7%). El 7% reingresaron por causa infecciosa. El 79% fueron dados de alta por evolución favorable. El 90% de los pacientes procedentes de urgencias tuvieron una evolución favorable. Conclusiones. Las ventajas de la hospitalización a domicilio para desarrollar programas de antibioterapia intravenosa en domicilio son evidentes. Más de la mitad de los pacientes procedieron del servicio de urgencias con una evolución favorable del 90%. Es precisa la presencia de personal médico y de enfermería cualificado en el tratamiento de enfermedades infecciosas y una asistencia continuada en domicilio (AU)

Objective. To assess the effectiveness of therapy, type of infection, hospital department of origin and outcome of 515 cases of infection requiring home intravenous antibiotic therapy treated by the home care service. Methods. The clinical records of patients undergoing intravenous antibiotic therapy through the home care service over a 6-year period were retrospectively reviewed. Results. A total of 439 patients (244M/195F; mean age, 55.9 years, range 7-96) requiring 515 courses of home intravenous antibiotic therapy were reviewed. Mean duration of antibiotic therapy was 7.9 days (1-58). Urinary (42.3%) and respiratory infections (25.8%) were the most frequent indications for home treatment. Most patients were referred from the emergency room (50.5%) followed by the Internal Medicine Department (11.5%) and Oncology Department (11.1%). Ceftriaxone was the most widely prescribed antibiotic (41.8%) followed by aminoglycosides (35.3%) and glycopeptides (11.7%). In 49 cases electronic infusion pumps were used, with ceftazidime being the predominant antibiotic (32.7%) in these cases. Hospitalization was required in 7% of patients due to infectious disease-related complications. Clinical outcome was positive in 79% of the patients, with improvement in 90% of patients from the emergency room Conclusions. The advantages of home care services to provide home intravenous antibiotic therapy are evident. More than half of the patients were referred from the emergency room and 90% of these progressed well. The presence of medical and nursing staff qualified to handle infectious diseases is necessary, as well as continuing home care (AU)

[Treatment of congestive heart failure in the setting of hospital at home. Study of 158 patients]. / Tratamiento de la insuficiencia cardíaca en régimen de hospitalización a domicilio. Estudio de 158 pacientes.

BACKGROUND AND OBJECTIVE: Hospital at Home might become a suitable alternative to traditional hospital admissions for several exacerbated chronic diseases. Congestive heart failure represents an important workload at the hospital level. In this study we present the results of our experience with congestive heart failure patients attended in Hospital at Home regimen during the period 1999-2001. PATIENTS AND METHOD: In 1999 we initiated a program to refer patients with congestive heart failure to Hospital at Home care. The program was agreed by the departments of emergency, cardiology, internal medicine and hospital at home. During the period 1999-2001, 158 patients (mean age = 76) were attended. Ninety one (58%) were women. At the moment of admission, 103 patients (68%) were on functional status IV of the NYHA. RESULTS: On average, patient's stay on hospital at home was 12,8 days. One hundred and twenty three (78%) of them were discharged, 29 (18%) had to be referred back to conventional hospitalisation and six (4%) died. During the 90 days following the discharge from Hospital at Home, the number of visits to the emergency department and the rate of hospital admissions decreased significantly. CONCLUSIONS: Our data confirm Hospital at Home as a valid option to conventional hospital admission for the management of patients with congestive heart failure.

Tratamiento de la insuficiencia cardíaca en régimen de hospitalización a domicilio. Estudio de 158 pacientes / Treatment of congestive heart failure in the setting of hospital at home. Study of 158 patients

FUNDAMENTO Y OBJETIVO: La hospitalización a domicilio puede convertirse en una alternativa real a la hospitalización tradicional en enfermedades crónicas reagudizadas como la insuficiencia cardíaca, que representa una carga asistencial importante en el ámbito hospitalario. En este trabajo presentamos los resultados de nuestra experiencia en el período 1999-2001 en pacientes con insuficiencia cardíaca atendidos en régimen de hospitalización a domicilio. PACIENTES Y MÉTODO: En 1999 se inició un programa de derivación de los pacientes con insuficiencia cardíaca a un régimen de hospitalización a domicilio en el Hospital Txagorritxu de Vitoria-Gasteiz, consensuado entre los Servicios de Urgencias, Cardiología, Medicina Interna y Hospitalización a Domicilio. Durante el período 1999-2001 se atendió a 158 pacientes con una edad media de 75,8 años siendo 91 (57,6 por ciento) mujeres. En el momento de su ingreso 103 pacientes (65,2 por ciento) se encontraban en grado funcional IV de la New York Heart Association. RESULTADOS: La estancia media de los pacientes fue de 12,8 días. Se pudo dar de alta a 123 pacientes (77,9 por ciento), 29 (18,3 por ciento) reingresaron en el hospital y 6 (3,8 por ciento) fallecieron. Se objetivó un descenso significativo tanto del número de visitas a urgencias como de los ingresos hospitalarios en los 90 días siguientes al alta del Servicio de Hospitalización a Domicilio. CONCLUSIONES: Nuestros datos confirman la validez de la hospitalización a domicilio como alternativa al ingreso hospitalario de pacientes con insuficiencia cardíaca descompensada (AU)